Detalhe da pesquisa
1.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38832989
2.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248424
3.
Burnout in oncology: Magnitude, risk factors and screening among professionals from Middle East and North Africa (BOMENA study).
Psychooncology
; 30(5): 736-746, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33427352
4.
Efficacy and Safety of Laughter Yoga in Cancer Patients: A Scoping Review of Randomized Controlled Trials.
Cureus
; 16(4): e59163, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38803758
5.
Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Associated Diabetic Ketoacidosis in Oncology Patients: A Case Series and Literature Review.
Cureus
; 16(2): e53816, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38465036
6.
Oncocytic Carcinoma with Liver Metastasis: Unusual Treatment Strategies and Clinical Insights-A Case Report and Review of the Literature.
Case Rep Oncol Med
; 2024: 3039762, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577565
7.
Oncotype DX in Breast Cancer Management: Insights and Outcomes From the United Arab Emirates.
Cureus
; 16(3): e56535, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516286
8.
Exploring Oral Cavity Cancer in the United Arab Emirates (UAE).
Cureus
; 16(2): e53452, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314383
9.
Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.
Clin Genitourin Cancer
; 22(2): 467-475, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228413
10.
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
Clin Genitourin Cancer
; 22(2): 305-314.e3, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087702
11.
Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR).
J Immunother Precis Oncol
; 7(2): 82-88, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721403
12.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481365
13.
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma.
BMC Urol
; 13: 26, 2013 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23688003
14.
Unilateral Axillary Lymphadenopathy in Cancer Patients Post-COVID-19 Vaccination: Review and Case Series.
Case Rep Oncol
; 16(1): 188-203, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033700
15.
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
Clin Exp Med
; 23(8): 5413-5422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917218
16.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530662
17.
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Target Oncol
; 18(4): 559-570, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369815
18.
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Clin Genitourin Cancer
; 21(5): e309-e319.e1, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062658
19.
Management of metastatic castration-resistant prostate cancer in Middle East African countries: Challenges and strategic recommendations.
Urol Ann
; 14(4): 303-313, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505997
20.
Prevalence and Risk Factors of Burnout Among Female Oncologists From the Middle East and North Africa.
Front Psychol
; 13: 845024, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35391953